MON-323 IGF-I Variability and Its Association with Demographic and Clinical Characteristics in Patients with Acromegaly Treated with Injectable Somatostatin Receptor Ligands (SRLS); Results from an International Prospective Phase III Study

Background: In clinical practice, most patients responding to injectable somatostatin receptor ligands exhibit IGF-I variability around the upper limit of normal (ULN) during long-term follow up. These fluctuations are thought to result from various factors such as assay variability, nutrition, como...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Endocr Soc
Main Authors: Samson, Susan Leanne, Nachtigall, Lisa B, Fleseriu, Maria, Ur, Ehud, Ludlam, William Henry, Patou, Gary, Haviv, Asi, Gilgun-Sherki, Yossi, Biermasz, Nienke, Strasburger, Christian Joseph, Kennedy, Laurence, Melmed, Shlomo
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Neuroendocrinology and Pituitary
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7207788/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.1907
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares